Search filters

List of works by Lisa A Carey

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer

scientific article published in 2022

Accrual of Older Patients With Breast Cancer to Alliance Systemic Therapy Trials Over Time: Protocol A151527

scientific article published on 19 December 2016

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

scientific article published on 24 May 2022

Age-specific changes in intrinsic breast cancer subtypes: a focus on older women

scientific article

Benchmarks for Academic Oncology Faculty

scientific article published on 30 September 2020

Borderline estrogen receptor-positive breast cancers in black and white women

scientific article published on 19 November 2019

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures.

scientific article

Changing Natural History of HER2-Positive Breast Cancer Metastatic to the Brain in the Era of New Targeted Therapies

scientific article published on 9 August 2017

Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update

scientific article published on 29 July 2021

Clinical significance of circulating tumor cells in hormone receptor-positive metastatic breast cancer patients who received letrozole with or without bevacizumab

scientific article published on 25 June 2020

Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer

scientific article published on 21 April 2020

Defining breast cancer intrinsic subtypes by quantitative receptor expression

scientific article published on 23 April 2015

Effect of cytotoxic chemotherapy on markers of molecular age in patients with breast cancer

scientific article

Effects of Breast Cancer Adjuvant Chemotherapy Regimens on Expression of the Aging Biomarker, <i>p16<sup>INK4a</sup></i>

scientific article published on 18 December 2020

Evaluating the Effectiveness of Neoadjuvant Chemotherapy in Reducing Mastectomy for Women With Breast Cancer

scientific article published on 23 September 2017

FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036

scientific article published on 12 May 2021

Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse.

scientific article

Independent Validation of the PAM50-Based Chemo-Endocrine Score (CES) in Hormone Receptor-Positive HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2-Based Therapy

scientific article published on 25 February 2021

LCCC 1025: a phase II study of everolimus, trastuzumab, and vinorelbine to treat progressive HER2-positive breast cancer brain metastases

scientific article published on 25 June 2018

Molecular characterization of basal-like and non-basal-like triple-negative breast cancer

scientific article published on 12 February 2013

Molecular features and survival outcomes of the intrinsic subtypes within HER2-positive breast cancer

scientific article

Neoadjuvant Systemic Therapy Use for Younger Patients with Breast Cancer Treated in Different Types of Cancer Centers Across the United States.

scientific article

Obesity, comorbidities, and treatment selection in Black and White women with early breast cancer

scientific article published on 07 December 2020

PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance).

scientific article

Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer

scientific article published on 14 December 2018

Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice

scientific article published on 15 May 2019

Patient-reported symptom severity, interference with daily activities, and adverse events in older and younger women receiving chemotherapy for early breast cancer

scientific article published on 20 November 2020

Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemotherapy for Locally Recurrent or Metastatic Breast Cancer: CALGB 40502/NC

scientific article published on 8 June 2015

Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial

scientific article published on 24 July 2019

TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases.

scientific article

TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes

scientific article published on 29 October 2020

The Phase II MutHER Study of Neratinib Alone and in Combination with Fulvestrant in HER2-Mutated, Non-amplified Metastatic Breast Cancer

scientific article published in 2022

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations

scientific article published on 10 August 2019

Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions

scientific article published on 10 August 2019

Weight changes in postmenopausal breast cancer survivors over 2 years of endocrine therapy: a retrospective chart review

scientific article published on 2 February 2017

Weight gain in hormone receptor-positive (HR+) early-stage breast cancer: is it menopausal status or something else?

scientific article published on 14 September 2017

Weight trajectories in women receiving systemic adjuvant therapy for breast cancer

scientific article published on 16 November 2019

What is the real impact of estrogen receptor status on the prognosis and treatment of HER2-positive early breast cancer?

scientific article published on 11 February 2020

Paulina is supported by:

About Paulina

Help